Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.

Shah S, Geetha D.

Immunotargets Ther. 2015 Aug 7;4:173-83. doi: 10.2147/ITT.S55516. eCollection 2015. Review.

2.

Refractory Granulomatosis with Polyangiitis Presenting as Facial Paralysis and Bilateral Sudden Deafness.

Kim SH, Jung AR, Kim SI, Yeo SG.

J Audiol Otol. 2016 Apr;20(1):55-8. doi: 10.7874/jao.2016.20.1.55. Epub 2016 Apr 21.

3.

Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Lazarus B, John GT, O'Callaghan C, Ranganathan D.

Indian J Nephrol. 2016 Mar-Apr;26(2):86-96. doi: 10.4103/0971-4065.171225. Review.

4.
5.

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives.

Moog P, Thuermel K.

Ther Clin Risk Manag. 2015 Nov 27;11:1749-58. doi: 10.2147/TCRM.S79080. eCollection 2015. Review.

6.

Pro: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?

Specks U.

Nephrol Dial Transplant. 2015 Jul;30(7):1083-7. doi: 10.1093/ndt/gfv217. Epub 2015 May 21.

7.

Make the grade for Wegener's granulomatosis after kidney transplantation.

Schewior L, Dragun D, Rudolph B, Schaeffner E.

NDT Plus. 2009 Jun;2(3):199-204. doi: 10.1093/ndtplus/sfp006. Epub 2009 Feb 2.

8.

Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.

Shang W, Ning Y, Xu X, Li M, Guo S, Han M, Zeng R, Ge S, Xu G.

PLoS One. 2015 May 14;10(5):e0126016. doi: 10.1371/journal.pone.0126016. eCollection 2015.

9.

Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.

Geetha D, Kallenberg C, Stone JH, Salama AD, Appel GB, Duna G, Brunetta P, Jayne D.

J Nephrol. 2015 Feb;28(1):17-27. doi: 10.1007/s40620-014-0135-3. Epub 2014 Sep 4. Review.

10.

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.

Marco H, Smith RM, Jones RB, Guerry MJ, Catapano F, Burns S, Chaudhry AN, Smith KG, Jayne DR.

BMC Musculoskelet Disord. 2014 May 25;15:178. doi: 10.1186/1471-2474-15-178.

11.

Rituximab-a drug with many facets and cures: a treatment for acute refractory hypoxemic respiratory failure secondary to severe granulomatosis with polyangiitis.

Powers B, Uppalapati A, Gogineni S, Jamkhana ZA.

Case Rep Crit Care. 2013;2013:123134. doi: 10.1155/2013/123134. Epub 2013 Feb 14.

12.

Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis.

Clain JM, Cartin-Ceba R, Fervenza FC, Specks U.

Ther Adv Musculoskelet Dis. 2014 Apr;6(2):58-74. doi: 10.1177/1759720X13516239. Review.

13.

Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.

Harrison AM, Thalji NM, Greenberg AJ, Tapia CJ, Windebank AJ.

Clin Transl Sci. 2014 Feb;7(1):82-6. doi: 10.1111/cts.12111. Epub 2013 Oct 3.

14.

Biologic agents in systemic vasculitis.

Henderson CF, Seo P.

Int J Clin Rheumtol. 2011;6(4):453-462.

15.

Novel strategy for the treatment of refractory vasculitis syndrome.

Yamada H.

Ann Vasc Dis. 2013;6(1):22-6. doi: 10.3400/avd.ra.12.00100. Epub 2013 Feb 15.

16.

Indomethacin-related leukocytoclastic vasculitis: a case report and review of literature.

Hussain N, Mustafa U, Davis J, Thakkar S, Ali AM, Mirrakhimov AE, Barbaryan A, Rowley GA.

Case Rep Dermatol. 2013 Jan;5(1):33-7. doi: 10.1159/000348240. Epub 2013 Feb 16.

17.

Update on diffuse alveolar hemorrhage and pulmonary vasculitis.

Krause ML, Cartin-Ceba R, Specks U, Peikert T.

Immunol Allergy Clin North Am. 2012 Nov;32(4):587-600. doi: 10.1016/j.iac.2012.08.001. Epub 2012 Sep 28. Review.

18.

Rituximab for refractory granulomatous eye disease.

Lower EE, Baughman RP, Kaufman AH.

Clin Ophthalmol. 2012;6:1613-8. doi: 10.2147/OPTH.S35521. Epub 2012 Oct 5.

19.

Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides.

Venhoff N, Effelsberg NM, Salzer U, Warnatz K, Peter HH, Lebrecht D, Schlesier M, Voll RE, Thiel J.

PLoS One. 2012;7(5):e37626. doi: 10.1371/journal.pone.0037626. Epub 2012 May 21.

20.

Rituximab in immunologic glomerular diseases.

Ejaz AA, Asmar A, Alsabbagh MM, Ahsan N.

MAbs. 2012 Mar-Apr;4(2):198-207. doi: 10.4161/mabs.4.2.19286. Epub 2012 Mar 1. Review.

Items per page

Supplemental Content

Write to the Help Desk